Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
The prevalence of obesity and the number of bariatric surgical procedures performed annually have increased during the past 20 years. Unfortunately, some bariatric surgical patients do not achieve meaningful weight loss or regain lost weight over time. The possibility that endoscopic therapies may lead to significant weight loss for these patients without the morbidity associated with revisional surgical procedures is appealing. It is not surprising that a number of companies have brought endoscopic devices designed to address this issue to market in recent years.
Gould JC. Weight Recidivism After Roux-en-Y Gastric BypassWe Need Better Data. JAMA Surg. 2014;149(4):379. doi:10.1001/jamasurg.2013.4076
Customize your JAMA Network experience by selecting one or more topics from the list below.